Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$0.84 - $1.43 $840 - $1,430
-1,000 Reduced 68.49%
460 $0
Q2 2023

Aug 14, 2023

BUY
$0.83 - $1.12 $830 - $1,120
1,000 Added 217.39%
1,460 $1,000
Q1 2023

May 12, 2023

SELL
$0.91 - $1.69 $177 - $329
-195 Reduced 29.77%
460 $0
Q4 2022

Feb 14, 2023

BUY
$1.09 - $2.04 $713 - $1,336
655 New
655 $0

Others Institutions Holding FIXX

About Homology Medicines, Inc.


  • Ticker FIXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 57,402,000
  • Description
  • Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...
More about FIXX
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.